The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Oncology Institute Inc shares valued at $23,584 were purchased by Virnich Daniel on Mar 26 ’25. At $1.04 per share, Virnich Daniel acquired 22,640 shares. The insider’s holdings grew to 724,363 shares worth approximately $1.41 million following the completion of this transaction.
Also, Podnos Yale purchased 9,056 shares, netting a total of over 9,434 in proceeds. Following the buying of shares at $1.04 each, the insider now holds 79,049 shares.
Before that, Pacala Mark L had added 90,562 shares to its account. In a trade valued at $94,338, the Director bought Oncology Institute Inc shares for $1.04 each. Upon closing the transaction, the insider’s holdings increased to 90,562 shares, worth approximately $0.44 million.
Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in mid September. As of August 15, 2022, Jefferies has initiated its “Buy” rating for TOI.
Analyzing TOI Stock Performance
During the last five days, there has been a surge of approximately 23.57%. Over the course of the year, Oncology Institute Inc shares have jumped approximately 527.83%. Shares of the company reached a 52-week high of $2.3500 on 04/14/25 and a 52-week low of $0.2519 on 01/10/25. A 50-day SMA is recorded $1.0544, while a 200-day SMA reached $0.5436.
Support And Resistance Levels for Oncology Institute Inc (TOI)
According to the 24-hour chart, there is a support level at 1.8133, which, if violated, would cause prices to drop to 1.6867. In the upper region, resistance lies at 2.0533. The next price resistance is at 2.1667. RSI (Relative Strength Index) is 75.69 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.3979, which suggests the price will decrease in the coming days. Percent R is at 29.71%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
